Boji Medical redeems maturing cash management products

Guangzhou Boji Medical & Biotechnological (SZSE:300404) announced the redemption of matured cash management products, previously purchased using temporarily idle raised funds. The company redeemed a CNY 2,000,000 product with Shanghai Pudong Development Bank, generating investment income of CNY 9,750. Boji Medical currently has CNY 2,000,000 still invested in such products. This strategy aligns with a board-approved plan from August 2024, allowing the company and its subsidiaries to manage up to CNY 60,000,000 in idle funds for cash management purposes, within a 12-month period.